Enveric Biosciences (ENVB) Stock Chart & Stock Price History $1.15 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.20 +0.05 (+3.91%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enveric Biosciences Stock Price Performance The Enveric Biosciences (ENVB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.55%, with a year-to-date return of -78.61%. In the past month, the stock has decreased 8.37%, reflecting recent market activity. As of the latest close, Enveric Biosciences traded at $1.15 with a market cap of $2.84 million and volume of 162,856 shares. Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.50%1 Month Performance-8.37%3 Month Performance-10.85%Year-To-Date Performance-78.61%1 Year Performance-86.55% ENVB Stock Chart for Monday, August, 4, 2025 ENVB Chart by TradingView Enveric Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$1.22$1.15-5.74%$1.23$1.14162,856 shs$2.84 million07/31/2025$1.23$1.22-0.81%$1.26$1.21106,414 shs$3.01 million07/30/2025$1.23$1.23$1.26$1.2148,177 shs$3.04 million07/29/2025$1.26$1.23-2.38%$1.30$1.2198,273 shs$3.04 million07/28/2025$1.31$1.26-3.82%$1.33$1.2482,951 shs$3.11 million07/25/2025$1.32$1.31-0.76%$1.34$1.2782,840 shs$3.24 million07/24/2025$1.37$1.32-3.65%$1.37$1.31137,381 shs$3.26 million07/23/2025$1.41$1.37-2.84%$1.40$1.33672,807 shs$3.39 million07/22/2025$1.37$1.41+2.92%$1.46$1.33258,391 shs$3.48 million07/21/2025$1.32$1.37+3.79%$1.40$1.33178,186 shs$3.38 million Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$1.28$1.32+3.13%$1.34$1.25149,488 shs$3.26 million07/17/2025$1.26$1.28+1.59%$1.29$1.24102,500 shs$3.16 million07/16/2025$1.23$1.26+2.44%$1.28$1.20148,883 shs$3.11 million07/15/2025$1.34$1.23-8.21%$1.29$1.181.06 million shs$3.04 million07/14/2025$1.31$1.34+2.29%$1.34$1.2940,768 shs$3.31 million07/11/2025$1.35$1.31-2.96%$1.36$1.3161,224 shs$3.24 million07/10/2025$1.35$1.35$1.36$1.3192,726 shs$3.34 million07/09/2025$1.29$1.35+4.65%$1.35$1.2885,173 shs$3.33 million07/08/2025$1.27$1.29+1.57%$1.31$1.2654,549 shs$3.19 million07/07/2025$1.26$1.27+1.20%$1.28$1.2540,841 shs$3.14 million07/04/2025$1.26$1.26$1.28$1.2435,571 shs$3.10 million07/03/2025$1.25$1.26+0.40%$1.28$1.2435,571 shs$3.10 million Related Companies BCDA Stock Price Chart SONN Stock Price Chart GOVX Stock Price Chart CSCI Stock Price Chart IBIO Stock Price Chart TRIB Stock Price Chart ACXP Stock Price Chart SNPX Stock Price Chart TAOX Stock Price Chart IMCC Stock Price Chart Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENVB) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
